← FDA DRUG APPROVALS
FDA ANDA · ANDA203048
CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER
Sponsor: RISING
APPLICATION
ANDA203048
TYPE
ANDA
ORIGINAL APPROVAL
2013-04-04
LATEST ACTION
2020-05-14
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINERPrescription
CLINDAMYCIN PHOSPHATE EQ 12MG BASE/ML · INJECTABLE · INJECTION
CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINERPrescription
CLINDAMYCIN PHOSPHATE EQ 18MG BASE/ML · INJECTABLE · INJECTION
CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINERPrescription
CLINDAMYCIN PHOSPHATE EQ 6MG BASE/ML · INJECTABLE · INJECTION
Approval history
2020-05-14Labeling · Supplement 1 · standardAP
2020-05-14Labeling · Supplement 8 · standardAP
2020-05-14Labeling · Supplement 4 · standardAP
2020-05-14Labeling · Supplement 2 · standardAP
2020-05-14Labeling · Supplement 3 · standardAP
2013-04-04UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.